Wade Thompson

24PUBLICATIONS
38CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsToxicology (incl. clinical toxicology)Cardiology (incl. cardiovascular diseases)Pharmaceutical delivery technologies
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (24)

|Aug 19, 2026
Glucagon-like peptide-1 receptor agonists for primary cardiovascular disease prevention in type 2 diabetes, a systematic review.

|Dec 13, 2025
Use of sodium-glucose cotransporter-2 inhibitors among older adults with type 2 diabetes mellitus in British Columbia.

Hanin Harbi, Gregory Carney, Colin Dormuth

|Nov 21, 2025
Appropriate Use of Proton Pump Inhibitors in Older Adults: Concerns and Solutions.

Jennifer Bolt, Wade Thompson, Colleen Inglis

|Oct 09, 2025
Pharmacotherapy for hypertension in adults 60 years or older.

Vijaya M Musini, Aaron M Tejani, Ken Bassett

|Aug 08, 2025
Association between dipeptidyl peptidase-4 inhibitors and glucagon-like peptide-1 receptor agonists and COVID-19 infection and adverse outcomes: a cohort study.

Wade Thompson, Bing Yu, Joan Porter

|Sep 17, 2024
Co-Designing a Consult Patient Decision Aid for Continuation Versus Deprescribing Cholinesterase Inhibitors in People Living with Dementia.

Nagham J Ailabouni, Wade Thompson, Sarah N Hilmer

Pageof 4

Frequent Collaborators

4 joint publications

Emily Reeve

3 joint publications

Jean-Pascal Fournier

3 joint publications

Carina Lundby

2 joint publications

Thomas Morel